Initially, the system was cleared for use in upper thoracic screw fixation. The new clearance allows for lateral mass and pedicle screws to be used as a form of fixation to treat different pathologies of the posterior cervical spine, making it one of the first FDA-cleared systems available in the United States for use of screws at C1-C7.
“Broadening the VERTEX Reconstruction System’s indication beyond current upper thoracic screw fixation displays Medtronic’s commitment to provide surgeons with the most innovative and effective surgical treatment options with the goal of improved patient care,” says Vincent Traynelis, MD, neurosurgeon at Rush University in Chicago.
More articles on devices:
7 key trends in joint replacement customization
Amedica files FDA application for spinal implant spacers with porous silicon nitride center — 6 things to know
Revenue up, $147k net loss — 10 key points on RTI Surgical’s 2014 financial report
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
